Category Business

FDA approves Biogen, Eisai treatment lecanemab

An MRI image of the brain shows the area of ​​an Alzheimer’s patient. Getty Images The Food and Drug Administration on Friday granted fast-track approval for the Alzheimer’s drug lecanemab, the second treatment of Biogen and Japanese partner Eisai to…